TherapeuticsMD (TXMD) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free TXMD Stock Alerts $1.89 +0.01 (+0.53%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media TherapeuticsMD Short Interest DataCurrent Short Volume45,200 sharesPrevious Short Volume47,400 sharesChange Vs. Previous Month-4.64%Dollar Volume Sold Short$103,508.00Short Interest Ratio / Days to Cover2.1Last Record DateMarch 31, 2024Outstanding Shares11,530,000 sharesFloat Size11,090,000 sharesShort Percent of Float0.41%Today's Trading Volume20,700 sharesAverage Trading Volume21,344 sharesToday's Volume Vs. Average97% Short Selling TherapeuticsMD ? Sign up to receive the latest short interest report for TherapeuticsMD and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTXMD Short Interest Over TimeTXMD Days to Cover Over TimeTXMD Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 TherapeuticsMD Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202445,200 shares $103,508.00 -4.6%0.4%2.1 $2.29 3/15/202447,400 shares $113,760.00 +15.9%0.5%2.4 $2.40 2/29/202440,900 shares $98,160.00 -18.9%0.4%1.8 $2.40 2/15/202450,400 shares $112,896.00 -8.2%0.5%2.6 $2.24 1/31/202454,900 shares $124,074.00 -57.7%0.5%2.5 $2.26 1/15/2024129,800 shares $295,944.00 -39.8%1.3%5.6 $2.28 Get the Latest News and Ratings for TXMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023215,600 shares $485,100.00 +143.1%N/A9.3 $2.25 12/15/202388,700 shares $207,558.00 -56.8%0.9%3.9 $2.34 11/30/2023205,400 shares $529,932.00 -4.1%2.0%9.4 $2.58 11/15/2023214,100 shares $505,276.00 -13.8%2.1%10.7 $2.36 10/31/2023248,500 shares $529,305.00 +162.4%2.4%13.1 $2.13 10/15/202394,700 shares $240,538.00 -8.7%0.9%4.8 $2.54 9/30/2023103,700 shares $313,174.00 -71.9%1.1%5.4 $3.02 9/15/2023369,000 shares $1.23 million +21.3%3.8%18.2 $3.33 8/31/2023304,300 shares $1.15 million -5.1%3.1%13.2 $3.79 8/15/2023320,700 shares $1.23 million -4.7%3.3%13.1 $3.84 7/31/2023336,400 shares $1.37 million -7.9%3.6%11.4 $4.06 7/15/2023365,100 shares $1.43 million +0.3%3.9%11.1 $3.93 6/30/2023364,200 shares $1.50 million +21.4%3.9%10.2 $4.12 6/15/2023300,100 shares $1.15 million +1.7%3.2%8 $3.84 5/31/2023295,100 shares $1.22 million -5.6%3.1%7.8 $4.15 5/15/2023312,600 shares $1.37 million -8.7%3.3%8.1 $4.39 4/30/2023342,400 shares $1.21 million +3.5%3.7%10 $3.54 4/15/2023330,900 shares $1.20 million +4.3%3.6%8.8 $3.62 3/31/2023317,200 shares $1.19 million +20.2%3.4%8 $3.75 3/15/2023263,800 shares $962,870.00 +10.4%3.0%5.5 $3.65 2/28/2023239,000 shares $1.19 million -11.2%2.7%1.9 $4.96 2/15/2023269,000 shares $1.38 million -5.4%3.2%2.1 $5.13 1/31/2023284,400 shares $1.50 million -12.1%3.2%2.1 $5.27 1/15/2023323,500 shares $1.75 million -4.1%3.8%2.4 $5.40 12/30/2022337,200 shares $1.88 million -26.2%4.0%2.5 $5.59 12/15/2022457,000 shares $3.03 million +46.8%5.4%3.4 $6.63 11/30/2022311,300 shares $1.43 million -19.5%3.7%2.4 $4.58 11/15/2022386,500 shares $2.29 million +12.9%4.6%5.4 $5.93 10/31/2022342,400 shares $2.17 million +2.4%4.1%2.7 $6.33 10/15/2022334,400 shares $2.15 million -3.3%4.0%1.2 $6.44 9/30/2022345,900 shares $2.30 million -5.9%4.2%0.8 $6.64 9/15/2022367,600 shares $2.87 million -11.2%4.4%0.6 $7.80 8/31/2022413,800 shares $4.10 million -33.3%5.0%0.5 $9.91 8/15/2022620,700 shares $5.74 million -32.6%8.0%0.6 $9.24Exposed: 10 CENT Crypto to Explode April 20th? (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 TXMD Short Interest - Frequently Asked Questions What is TherapeuticsMD's current short interest? Short interest is the volume of TherapeuticsMD shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 45,200 shares of TXMD short. 0.41% of TherapeuticsMD's shares are currently sold short. Learn More on TherapeuticsMD's current short interest. What is a good short interest ratio for TherapeuticsMD? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TXMD shares currently have a short interest ratio of 2.0. Learn More on TherapeuticsMD's short interest ratio. What is a good short interest percentage for TherapeuticsMD? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of TherapeuticsMD's floating shares are currently sold short. Is TherapeuticsMD's short interest increasing or decreasing? TherapeuticsMD saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 45,200 shares, a decline of 4.6% from the previous total of 47,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TherapeuticsMD's float size? TherapeuticsMD currently has issued a total of 11,530,000 shares. Some of TherapeuticsMD's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TherapeuticsMD currently has a public float of 11,090,000 shares. How does TherapeuticsMD's short interest compare to its competitors? 0.41% of TherapeuticsMD's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TherapeuticsMD: Cumberland Pharmaceuticals Inc. (0.21%), Cardio Diagnostics Holdings, Inc. (2.53%), Biora Therapeutics, Inc. (4.16%), Nephros, Inc. (0.03%), DermTech, Inc. (10.31%), NeuroSense Therapeutics Ltd. (0.70%), MEI Pharma, Inc. (0.13%), OncoCyte Co. (2.36%), Evaxion Biotech A/S (0.82%), PolyPid Ltd. (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short TherapeuticsMD stock? Short selling TXMD is an investing strategy that aims to generate trading profit from TherapeuticsMD as its price is falling. TXMD shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TherapeuticsMD? A short squeeze for TherapeuticsMD occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TXMD, which in turn drives the price of the stock up even further. How often is TherapeuticsMD's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXMD, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Cumberland Pharmaceuticals Short Interest Cardio Diagnostics Short Interest Biora Therapeutics Short Interest Nephros Short Interest DermTech Short Interest NeuroSense Therapeutics Short Interest MEI Pharma Short Interest OncoCyte Short Interest Evaxion Biotech A/S Short Interest PolyPid Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TXMD) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry